Evidence map›Paper›PMID 32270680›Full record

ArticleJournal of proteome research2020

Quality Control and Outlier Detection of Targeted Mass Spectrometry Data from Multiplex Protein Panels.

Irene van den Broek, Mitra Mastali, Kelly Mouapi, Cory Bystrom, C Noel Bairey Merz, Jennifer E Van Eyk

Abstract read
In one paragraph

Article in Journal of proteome research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Novel Strategies to Address the Challenges in Top-Down Proteomics.Journal of the American Society for Mass Spectrometry · 2021
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Irene van den BroekCedars-Sinai Precision Biomarker Laboratories, Cedars-Sinai Medical Center, 127 S. San Vicente Blvd., Pavilion, 9th Floor, Los Angeles, California 90048, United States.ORCID 0000-0002-5276-8623
Mitra MastaliCedars-Sinai Precision Biomarker Laboratories, Cedars-Sinai Medical Center, 127 S. San Vicente Blvd., Pavilion, 9th Floor, Los Angeles, California 90048, United States.
Kelly MouapiAdvanced Clinical BioSystems Research Institute, The Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.
Cory BystromCedars-Sinai Precision Biomarker Laboratories, Cedars-Sinai Medical Center, 127 S. San Vicente Blvd., Pavilion, 9th Floor, Los Angeles, California 90048, United States.
C Noel Bairey MerzBarbra Streisand Women's Heart Center, The Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.
Jennifer E Van EykCedars-Sinai Precision Biomarker Laboratories, Cedars-Sinai Medical Center, 127 S. San Vicente Blvd., Pavilion, 9th Floor, Los Angeles, California 90048, United States.ORCID 0000-0001-9050-148X

Funding

Genomic and Proteomic Architecture of AtherosclerosisR01HL111362 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HERRINGTON, DAVID MCLEOD · 2012 to 2021
$17.2M
NHLBI NIH HHS R01 HL111362
6 · The paper itself

Abstract

Increased throughput as well as increased multiplexing of liquid chromatography coupled to selected reaction monitoring mass spectrometry (LC-SRM-MS) assays for protein quantification challenges routine data analysis. Despite the measurement of multiple transitions from multiple peptides, for clinical applications a single (quantifier) transition from one (quantifier) signature peptide is used to represent the protein quantity with most data used solely to validate the quantifier result. To support the generation of reliable protein results from multiplexed LC-SRM-MS assays with large sample numbers, we developed a data analysis process for quality control and outlier detection using data from an 11-protein multiplex LC-SRM-MS method for dried blood samples (195 492 chromatographic peaks from 1481 samples * 11 proteins * 2 peptides * 3 transitions * 2 isotopologues). The 2-tiered data analysis process detects outliers for ion transition ratio, peptide ratio, and % difference between duplicates, applying less stringent criteria to samples with a small % difference between duplicates (Tier 1) and more stringent criteria to samples with unassessed or a large % difference between duplicates (Tier 2). After manual peak review, 1127 samples (76%) were selected based on the sample quality. The data analysis process thereafter automatically selected quantifier transitions/peptides, removed quality control failures and outliers (8%), averaged duplicates, and generated a comprehensive report listing 6085 quality controlled protein-level results. The proposed data analysis process serves as a starting point toward standardized data analysis of multiplexed LC-SRM-MS protein assays.

Indexed as

PeptidesChromatography, LiquidMass SpectrometryQuality ControlPeptidesabsolute quantificationbiomarker validationbottom-up proteomicsdata analysisdried blood microsamplingion transition ratiopeptide ratio

Identifiers

PMID32270680
PMCPMC12316323

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.